In the evolving landscape of mental health treatments, ketamine and psilocybin therapies have gained significant attention as innovative options for conditions like treatment-resistant depression, anxiety, and PTSD.  Both draw from the realm of dissociative and psychedelic substances, yet they differ markedly in their mechanisms, delivery, and crucially their costs and accessibility. For many seeking relief […]